Trials / Completed
CompletedNCT02811367
The HPV Self-test as a Test of Cure in Madagascar
The HPV Self-test as a Test of Cure in the Follow-up of HPV-positive Women in Madagascar
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 117 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to find out whether Self-HPV may be an accurate method for the follow-up of women with a history of HPV infection.
Detailed description
The efficacy and the availability of cold coagulation render it a valuable technique for the treatment of precancerous lesions in low-resource settings. The Human Papillomavirus (HPV) test performed by women themselves (HPV self-test) could be an efficient method to assess the long-term risk of recurrent/persistent disease in women with a history of HPV infection and cervical intra-epithelial lesions grade 2 or higher (CIN2+). A total of 443 HPV-positive women, aged 30-65 years, have been selected through a screening campaign conducted in Ambanja, Madagascar, between 2013 and 2015. Of these, 260 have been treated by cold coagulation, conisation or electrocauterization. A follow-up visit at 1-3 years after primary screening will be organized for all HPV-positive women detected at primary screening. Participants will perform an HPV self-test. A sample for cytology and HPV testing will also be collected by the physician. The goal of the study will be the histological search for CIN2+ lesions at one to three years after primary screening. The investigators expect to see that Self-HPV may be an accurate method for the follow-up of women with a history of HPV infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HPV test | Women will perform the HPV self-test and will also undergo a physician-performed HPV test. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-06-23
- Last updated
- 2016-10-17
Locations
1 site across 1 country: Madagascar
Source: ClinicalTrials.gov record NCT02811367. Inclusion in this directory is not an endorsement.